Article
Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation.
Oncogene - 30 Apr 2009
Ciarapica R, Annibali D, Raimondi L, Savino M, Nasi S, Rota R
Abstract excerpt
Inhibitor of DNA-binding (Id) proteins prevent cell differentiation, promote growth and sustain tumour development. They do so by binding to E proteins and other transcription factors through the helix-loop-helix (HLH) domain, and inhibiting transcription. This makes HLH-mediated Id protein interactions an appealing therapeutic target. We have used the dominant interfering HLH dimerization mutant 13I to model the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
